Healthcare · coverage Jan 8, 2024–Sep 12, 2026
Estimated market comparison · not an official filing fact
Available with Pro
Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.
Disclosure alert preview
Based on a real public filing
Thomas H. Kean
$1K - $15K
This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Sep 28, 2026.
Official filingThis page summarizes public STOCK Act disclosures involving JNJ. It is useful for seeing which lawmakers reported JNJ transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Sep 12, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
Congressional Trader tracks 72 public STOCK Act disclosures for JNJacross 26 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent JNJ filing shown here was filed on Sep 12, 2026 by Thomas H. Kean as a partial sale. Related lawmakers include Lloyd Doggett, Josh Gottheimer, Lisa C. McClain, Marjorie Taylor Greene, Kevin Hern.
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansRecent JNJ disclosures include Lloyd Doggett, Josh Gottheimer, Lisa C. McClain, Marjorie Taylor Greene, Kevin Hern.
The visible sample currently shows 49 purchases and 23 sales or partial sales.
No. This page summarizes public filings for research and monitoring. It is not investment advice.
